University of Nebraska — Omaha, Nebraska

Public research footprint of University of Nebraska, compiled from the ClinicalTrials.gov public registry.

1,726

Registered studies

534

Active

262

Recruiting now

932

Completed

211

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6… · Metastatic Bladder Large Cell Neuroendocrine Carcinoma · Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6…

Recently updated registry entries

NCT06203210 — A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With… (Recruiting)
NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT07061977 — Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Nebraska?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.